🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Live from #ASCO24: Poster presentation from Dana-Farber's Catherine Marinac, PhD, who evaluated the success of MCED tests among cancer survivors.

Congratulations to Katie Greenzang, MD, EdM Dana-Farber/Boston Children's who is the 2024 recipient of the American Society of Pediatric Hematology/Oncology (American Society of Pediatric Hematology/Oncology) Childhood Cancer Survivorship Award for Excellence. Read more ms.spr.ly/6016Y26eK

Save the date ! "Opportunities for Cancer Genetics and Precision Medicine in Africa" on August 14th from 9:30am-1pm in Yawkey 306. Dana-Farber DF/HCC Harvard Zhu Center for Global Cancer Prevention AORTIC Please register to attend: docs.google.com/forms/d/e/1FAI…

Great article featuring Keishla Arce and Dr. Jenny Mack, Associate Chief of Dana-Farber Division of Population Sciences highlighting the importance of diversity in science bostonglobe.com/2024/09/10/mag…

The DF/HCC is pleased to announce we are accepting applications for the T32 postdoctoral fellowship training program. A great opportunity for MDs or PhDs to pursue a career in cancer‐related population sciences. Applications due 12/17/24. Visit TOPSPostdoc.org to apply.

Hi folks, we have new faculty open search in Dana-Farber Division of Population Sciences Dana-Farber Harvard Medical School, seeking folks interested in launching an independent research program across our very diverse and interdisciplinary set interests! See link for more info: careercenter.asco.org/job/7622758/as…

At our annual Symposium & Awards Luncheon, Dr. Judy Garber will receive BCRF's highest scientific honor: the Jill Rose Award for Scientific Excellence in recognition of her outstanding contributions not only to BCRF but to the entire breast cancer field. bit.ly/3BVYCdo

Thank you Chris Manz Tom Abrams Dana-Farber Division of Population Sciences Dana-Farber for the opportunity to work on this project. x.com/JournalCancer/… #HPBCSM #oncology #livercancer #GI #liver #transplant #TARE #TACE #y90 #ablation #EBRT #SBRT #DanaFarber #ICIs #Pembro

After a median follow-up of 6 years, patients with high-risk, BRCA+ breast cancer receiving olaparib after standard therapy showed significant improvements in survival outcomes, according to updated OlympiA data presented by Dana-Farber’s Judy Gaber, MD, at today’s #SABCS24.

A new consensus report from National Academies, chaired by Dana-Farber's Vish Viswanath, provides a comprehensive assessment of the literature on science misinformation, its origins and impact, and strategies for mitigating its spread and potential harms. ➡️ bit.ly/49TyCw9

In a study published in JAMA Oncology, Dana-Farber researchers, led by Gregory Abel, MD, find care after donor stem cell transplant can be safely shared between transplant centers and local oncologists. The Patient-Centered Outcomes Research Institute Read more here: bit.ly/40oa1fU

On the heels of the surgeon general's warning about the cancer risks of alcohol, there's a growing consensus that less is better. Tim Rebbeck, professor of cancer prevention Dana-Farber, talked to NPR: n.pr/42bbiby

#WorldCancerDay is less than one week away! We are excited to work with Harvard T.H. Chan School of Public Health Dana-Farber to offer two panel discussions on Monday, February 3rd. Use the QR codes to register and receive a link to watch online.

.Dana-Farber’s Temidayo Fadelu, MD, and colleagues share new insights in JAMA Oncology on advancing pharmacoequity in low and middle-income countries around the globe. ➡️ bit.ly/3WLA7Hs

Check out this recent JAMA Network Open on Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes 🔓pubmed.ncbi.nlm.nih.gov/39745704/ Brittany Bychkovsky, MD Nihat Buğra Ağaoğlu judy garber Huma Rana, MD, MPH

Our new bulletin board is up, showcasing the work we’re doing in exercise oncology. 💡 What’s on the board? ✅ Info about our lab & mission ✅ Ongoing clinical trials ✅ How YOU can get involved! Join us in redefining cancer care through movement. Exercise is Medicine! 💙

.TODAY’s Craig Melvin reports from Dana-Farber, where Matthew Yurgelun, MD, director of the Lynch Syndrome Center, is leading groundbreaking research to find cancer before it spreads: bit.ly/3XzbmP3 Dana-Farber's Young-Onset Colorectal Cancer Center #ColorectalCancerAwarenessMonth

False health information can lead to confusion and poor decisions. Vish Viswanath, PhD, shares insights on how to spot misinformation and find trusted sources. Swipe for tips and learn more here: bit.ly/4iLFYoB

Thinking about the way of the world, a chat ~25 years ago about a new camp for kids whose parents have cancer, and (soon-to-be) Dr. Jett Crowdis today He shares his motivations in medicine, the link to Kesem, and our science in Harvard University Gazette news.harvard.edu/gazette/story/…

Dr. Michael Hassett discusses the outcomes of an electronic patient-reported outcomes (#ePRO)–based #SymptomManagement Program (#eSyM) at #ASC025. #SIMPRO #PatientReportedOutcomes